Resources from the same session
Optimal management of toxicity in patients with advanced NSCLC treated with EGFR E20I inhibitors: Are they all similar?
Presenter: R. A. Soo, SG
Session: Session 4 – Clinical challenges
Resources:
Slides
Webcast
Emerging mechanisms of resistance to EGFR E20I inhibitors and research on combinations of EGFR E20I inhibitors with cytotoxic chemotherapy or novel targeted therapeutics
Presenter: F. Cappuzzo, IT
Session: Session 4 – Clinical challenges
Resources:
Slides
Webcast